Study on biodistribution of ~(131)iodine labeled monoclonal antibody D-D_3 against pro-gastrin-releasing peptide_((31-98)) in healthy Kunming mice

Chen Chuanxin,Shi Yizhen,Yang Yi,Tang Jun,Liu Zengli,Xu Qiaoling

2011-01-01

Abstract:Objective To study the 131I labeling methods,stability,and biological distribution pattern of D-D3 antibody against pro-gastrin-releasing peptide 31-98(ProGRP(31-98)).MethodsThe radioiodination of D-D3 antibody was performed using the chloramine-T method.The radiochemical purity was determined through thin-layer chromotography.131I-D-D3 was injected into the healthy Kunming mice via a tail vein,and the %ID/g for various organs was obtained,and then,the biodistribution and pharmacokinetics of 131I-D-D3 antibody in healthy Kunming mice were studied.ResultsThe 131I-D-D3 labeling rate was(86.56±3.8)%.The radiochemical purity of 131I-D-D3 was(99.27±0.6)%.After 48 h incubating in 37 ℃ water bath,the radiochemical purity was(88.38±0.4)%.While being mixed 24 h with healthy human serum,the radiochemical purity was still more than(64.43±0.7)%.The metabolism of 131I-D-D3 in healthy Kunming mice was consistent with a two-compartment model with first-order absorption,T1/2α and T1/2β was 0.25,37.89 h,respectively.ConclusionThe labeling efficiency and radiochemical purity of 131I-D-D3 are high and stable.131I-D-D3 is a promising radioimmunoimaging reagent for small cell lung cancer(SCLC).